The Faculty has prepared a general guidance document to assist doctors in preparing for appraisal and revalidation. Click here to access this document.
Please click here
For guidance on using the PReP e-system please visit the information provided on the E-system page of our website - click here.
Should you be interested in this role, please contact us at email@example.com
The Faculty of Pharmaceutical Medicine welcomes the launch of revalidation in supporting doctors in keeping their professional practice up to date. The process will also provide patients with a further level of confidence that doctors are fit to practise in their specialty areas. The Faculty has issued guidance to the membership on the revalidation process via this website and the themed revalidation newsletter issued in July 2012. This guidance will be updated on a regular basis.
Any queries regarding revalidation should be addressed to firstname.lastname@example.org
Early next year (2013) we will be launching an e-system to enable doctors who have a prescribed connection with the Faculty designated body to store and manage their supporting information required for appraisal.
Further information on revalidation can be found on the GMC website.
In July 2012, the Faculty published a special edition of the newsletter dedicated to revalidation and how it affects pharmaceutical physicians. Please download a copy of the newsletter here. This page will be updated as new information becomes available. The newsletter contains a report on the findings from the Tri-Faculty Revalidation pilot.
Revalidation is the process by which licensed doctors will, in future, be required to demonstrate to the GMC, on a regular basis, that they remain up to date and fit to practise. Revalidation will be based on a local evaluation of doctors' performance against national generic and specialty standards approved by the GMC in order to maintain their licence to practice.
The purpose of revalidation is to assure patients and the public that licensed doctors are up to date and practising in accordance with the values and principles set out in the GMC's core ethical guidance for doctors Good Medical Practice (GMP).
Doctors will be expected to participate in annual appraisal in the workplace and will be required to collect information about their professional practice which demonstrates that they are practising to the appropriate professional standards. This information will provide the basis for discussion at an annual appraisal.
The Good Medical Practice Framework for Appraisal and Revalidation is based on the core guidance - Good Medical Practice (2006) and will form the basis of a standard approach for appraisal. The GMC document Supporting Information for Revalidation and Appraisal provides guidance regarding the supporting information that you will need to provide at your annual appraisal and the frequency with which it should be provided.
Every five years, the doctor's Responsible Officer will make a submission to the GMC about the doctor's suitability to be revalidated. This submission will be based on the outcome of the doctor's annual appraisals over the course of five years together with information drawn from local governance systems. The GMC's decision whether or not to revalidate a doctor for a further five years will be based on the Responsible Officer's submission.
On 19 October 2012, the Secretary of State for Health, Jeremy Hunt, announced that the introduction of revalidation would take place on 3 December 2012.
It is anticipated that the vast majority of doctors will have completed their first revalidation cycle by 31 March 2016; thereafter, doctors will normally revalidate every 5 years. It should be noted that, regardless of your revalidation date, you will be required to undergo annual appraisal with effect from the date of introduction of revalidation.
If you have any queries, whether or not you are a member of the Faculty, please contact Susan Paterson, Professional Development Administrator or Dr Susan Bews, Responsible Officer, via email to email@example.com or phone 020 7831 7662 extension 24.
The final evaluation report on the Tri-Faculty revalidation pilot is now available on the Academy of Medical Royal Colleges website at: http://www.aomrc.org.uk/publications/reports-a-guidance.html
'When the pharmaceutical industry submits documents to the MHRA, which are signed by a medical practitioner, it would normally be expected that the person would be a licensed medical practitioner'.
For further information on:
Other useful documents: